Retour
66
33
Fourchette du Jour
12,12 €
12,85 €
Fourchette 52 Semaines
11,20 €
23,80 €
Volume
9 437 594
Moyenne 50J / 200J
14,26 €
/
16,25 €
Clôture Précédente
12,63 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -7,1 | 0,4 |
| P/B | 3,2 | 2,9 |
| ROE % | -44,5 | 3,7 |
| Net Margin % | -3,8 | 3,8 |
| Rev Growth 5Y % | 57,1 | 10,0 |
| D/E | 0,4 | 0,2 |
Points Clés
Revenue grew 57,10% annually over 5 years — strong growth
Earnings declined -1842,49% over the past year
Debt/Equity of 0,44 — conservative balance sheet
Generating 1,06B in free cash flow
PEG of 0,01 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 29,60%
Croissance
Revenue Growth (5Y)
57,10%
Revenue (1Y)27,50%
Earnings (1Y)-1842,49%
FCF Growth (3Y)N/A
Qualité
Return on Equity
-44,51%
ROIC-21,12%
Net Margin-3,79%
Op. Margin-3,39%
Sécurité
Debt / Equity
0,44
Current Ratio0,95
Interest Coverage-22,52
Valorisation
P/E Ratio
-7,14
P/B Ratio3,24
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 27,50% | Revenue Growth (3Y) | 41,27% |
| Earnings Growth (1Y) | -1842,49% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 57,10% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 11,70B | Net Income (TTM) | -443,15M |
| ROE | -44,51% | ROA | -7,01% |
| Gross Margin | 14,38% | Operating Margin | -3,39% |
| Net Margin | -3,79% | Free Cash Flow (TTM) | 1,06B |
| ROIC | -21,12% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,44 | Current Ratio | 0,95 |
| Interest Coverage | -22,52 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -7,14 | P/B Ratio | 3,24 |
| P/S Ratio | 0,27 | PEG Ratio | 0,01 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 3,17B | Enterprise Value | 821,67M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 11,70B | 9,18B | 5,86B | 4,13B | 1,92B |
| Net Income | -443,15M | 25,43M | -270,73M | -606,28M | -572,61M |
| EPS (Diluted) | -1,69 | 0,10 | -1,22 | -2,85 | -3,19 |
| Gross Profit | 1,68B | 1,84B | 1,22B | 4,13B | 1,92B |
| Operating Income | -396,36M | 57,27M | -235,62M | -610,08M | -570,58M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 6,33B | 4,84B | 3,60B | 4,53B | 3,32B |
| Total Liabilities | 5,34B | 3,82B | 2,80B | 3,63B | 1,93B |
| Shareholders' Equity | 977,65M | 1,01B | 803,97M | 890,38M | 1,39B |
| Total Debt | 430,10M | 299,56M | 298,78M | 298,00M | 0,0 |
| Cash & Equivalents | 2,77B | 1,53B | 1,87B | 1,56B | 1,10B |
| Current Assets | 4,61B | 2,85B | 2,07B | 4,12B | 2,77B |
| Current Liabilities | 4,86B | 3,17B | -175,28M | 3,26B | 1,62B |
Scores de Stratégies
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
#107 of 616
Custom
Full Throttle
#102 of 146
Activité Récente
Entré
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Entré
Full Throttle
Mar 24, 2026